GoodRx Holdings Statistics
Want to see GDRX full AI Analyst Report?
GoodRx Holdings (GDRX) Stock Statistics & Valuation Metrics
Total Valuation
GoodRx Holdings has a market cap or net worth of $1.21B. The enterprise value is $1.25B.
- Market Cap
- $1.21B
- Enterprise Value
- $1.25B
Share Statistics
GoodRx Holdings has 107,181,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 107,181,200
- Owned by Insiders
- 13.02%
- Owned by Institutions
- 81.87%
Financial Efficiency
GoodRx Holdings’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.03%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 4.03%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 1.14M
- Profits Per Employee
- 43.67K
- Employee Count
- 697
- Asset Turnover
- 0.57
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of GoodRx Holdings is 67.68. GoodRx Holdings’s PEG ratio is -1.20.
- PE Ratio
- 67.68
- PS Ratio
- 1.55
- PB Ratio
- 1.87
- Price to FCF
- 8.33
- Price to Operating Cash Flow
- 5.99
- PEG Ratio
- -1.20
Income Statement
In the last 12 months, GoodRx Holdings had revenue of 796.85M and earned 30.44M in profits. Earnings per share was 0.09.
- Revenue
- 796.85M
- Gross Profit
- 739.26M
- Operating Income
- 87.49M
- Pretax Income
- 56.54M
- Net Income
- 30.44M
- EBITDA
- 184.36M
- Earnings Per Share (EPS)
- 0.09
Cash Flow
In the last 12 months, operating cash flow was 201.58M and capital expenditures -55.84M, giving a free cash flow of 145.75M billion.
- Operating Cash Flow
- 201.58M
- Free Cash Flow
- 145.75M
- Free Cash Flow per Share
- 0.43
Dividends & Yields
GoodRx Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 12.00%
- Earnings Yield
- 1.35%
Stock Price Statistics
- Beta
- 1.33
- 52-Week Price Change
- 15.96%
- 50-Day Moving Average
- 3.44
- 200-Day Moving Average
- 2.88
- Relative Strength Index (RSI)
- 52.05
- Average Volume (3m)
- 1.14M
Important Dates
GoodRx Holdings upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
GoodRx Holdings as a current ratio of 2.61, with Debt / Equity ratio of 88.08%
- Current Ratio
- 2.61
- Quick Ratio
- 2.61
- Debt to Market Cap
- 0.51
- Net Debt to EBITDA
- 1.52
- Interest Coverage Ratio
- 2.05
Taxes
In the past 12 months, GoodRx Holdings has paid 26.10M in taxes.
- Income Tax
- 26.10M
- Effective Tax Rate
- 0.46
Enterprise Valuation
GoodRx Holdings EV to EBITDA ratio is 8.53, with an EV/FCF ratio of 10.00.
- EV to Sales
- 1.86
- EV to EBITDA
- 8.53
- EV to Free Cash Flow
- 10.00
- EV to Operating Cash Flow
- 7.23
Balance Sheet
GoodRx Holdings has $296.11M in cash and marketable securities with $538.95M in debt, giving a net cash position of -$242.84M billion.
- Cash & Marketable Securities
- $296.11M
- Total Debt
- $538.95M
- Net Cash
- -$242.84M
- Net Cash Per Share
- -$2.27
- Tangible Book Value Per Share
- $0.06
Margins
Gross margin is 88.05%, with operating margin of 10.25%, and net profit margin of 2.07%.
- Gross Margin
- 88.05%
- Operating Margin
- 10.25%
- Pretax Margin
- 5.27%
- Net Profit Margin
- 2.07%
- EBITDA Margin
- 21.76%
- EBIT Margin
- 10.47%
Analyst Forecast
The average price target for GoodRx Holdings is $3.33, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
- Price Target
- $3.33
- Price Target Upside
- 6.60% Downside
- Analyst Consensus
- Moderate Sell
- Analyst Count
- 2
- Revenue Growth Forecast
- -1.83%
- EPS Growth Forecast
- -48.77%
Scores
- Smart Score
- 3
- AI Score
- 63

